Stopping Aspirin 3 Months After Stent Is Safe, Study Finds




Source: https://www.drugs.com/news/stopping-aspirin-3-months-after-stent-safe-study-finds-81168.html?utm_source=ddc&utm_medium=rss&utm_campaign=Stopping+Aspirin+3+Months+After+Stent+Is+Safe%2C+Study+Finds

Stopping Aspirin 3 Months After Stent Is Safe, Study Finds



Medtronic has provided this analysis to allow physicians to make 'best' decisions in the pay for Performance Works: HealthLeaders Media difficult circumstance where a patient has to, or wants to, stop therapy. I'm amazed that it's going forward.". A little more than three-quarters of the study participants took clopidogrel, the most common P2Y12 inhibitor, with the rest taking either prasugrel or ticagrelor. I might be more concerned if it were one or two, but it was zero!". In addition, patients who stopped taking aspirin after three months had a significantly lower rate of bleeding. Treatment for...

The data strongly suggests that for the patients in the studies from which this data was derived, it was safe to discontinue 'early'." Interestingly most of the stent thromboses seen in this group of patients occurred within. This labeling update applies to product distributed in countries that accept the CE mark. Interestingly, these patients who constituted the vast majority of those who interrupted their dual antiplatelet therapy after one month experienced no instances of stent thrombosis (0.0) through one year of follow-up. The results of this analysis are but the most recent evidence that the newer second and third generation drug-eluting stents are safer and more effective than their predecessors, and that much of the concern raised seven years ago now has been addressed. The trial included nearly 3,000 patients in South Korea who received a drug-eluting stent, which releases drugs to prevent new blockages. Overall, 2 percent of those stopping aspirin experienced major bleeding compared.4 percent among those following standard dapt.